In one of the largest tests to date, researchers find that satellites reliably spot the greenhouse gas across the board ...

Over $1 billion sat unused in US National Science Foundation (NSF) accounts as fiscal 2026 came to a close Oct. 1. A White ...

HydRegen’s scientists are commercializing hydrogenase systems that work in conventional chemical reactors. Credit: HydRegen Enzymes are powerful tools for chemical synthesis, but their natural setting ...

After successfully completing our previous strategic plan, we developed a new strategic plan in 2025. At its heart is our ...

In a recent related study, researchers in China also developed a heterogeneous hydroformylation catalyst based on rhodium. The group also uses nitrogen-containing molecules to enhance catalytic ...

Biotechs in the US and Europe face challenges, but as a recent panel discussion made clear, the competition offers global ...

To refine rare earths, Alta’s engineers attach the proteins to chromatography resin that is used to separate the elements.

Finally, we should be worried about how these trial markets could impact public perception of the drug development and ...

The 2026 chemistry Nobel announcement sparked a frenzy of chirality fact-checking. Turns out, nailing stereochemistry is ...

Start-up seeks to take artificial intelligence beyond generating molecules and into the lab to help medicinal chemists save ...

Legislation introduced last week could speed up federal approvals for energy and other major projects, but its fate remains uncertain ...

Estuary is now plotting human trials that will begin in 2027 and 2028. The first will test EST-201, a Pkd2 gene therapy for ...